A comparative bioavailability study of two formulations of pregabalin in healthy Chilean volunteers

11Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objective: The aim of this study was to compare the pharmacokinetic parameters between two brands of pregabalin in healthy Chilean volunteers. Methods: A randomized, single-dose, two-period, two-sequence, crossover study design with a 2-week washout period was conducted in healthy Chilean males. Plasma samples were collected over a 12-hour period after administration of 150 mg pregabalin in each period. A validated ultra-performance liquid chromatography with positive ionization mass spectrometric detection method was used to analyze pregabalin concentration in plasma. Pharmacokinetic parameters were determined using a noncompartmental method. Bioequivalence between the test and reference products was determined when the ratio for the 90% confidence intervals (CIs) of the difference in the means of the log-transformed area under the curve (AUC)0-t, AUC0-∞, and maximum concentration (Cmax) of the two products were within 0.80 and 1.25. Results: The study was carried out on 22 healthy Chilean volunteers. The mean (SD) Cmax, AUC0-t and AUC0-∞ of the test formulation (PregobinTM) of pregabalin were 2.10 (0.56) µg/ml, 10.35 (2.00) µgxh/ml and 13.92 (2.74) µgxh/ml, respectively. The mean (SD) Cmax, AUC0-t and AUC0- ∞ of the reference formulation (LyricaTM) of pregabalin were 2.15 (0.52) µg/ml, 10.31 (1.85) µgxh/ml and 13.78 (2.25) µgxh/ml, respectively. The parametric 90% CIs for Cmax, AUC0-t, and AUC0-∞ were 0.97'1.13, 1.01'1.04, and 0.98'1.02, respectively. Conclusions: These results suggest that both products are bioequivalent and can be used as interchangeable options in the clinical setting. © 2010, SAGE Publications. All rights reserved.

Cite

CITATION STYLE

APA

Quinones, L., Sasso, J., Tamayo, E., Catalan, J., Gonzalez, J. P., Escala, M., … Saavedra, I. (2010). A comparative bioavailability study of two formulations of pregabalin in healthy Chilean volunteers. Therapeutic Advances in Chronic Disease, 1(4), 141–148. https://doi.org/10.1177/2040622310379932

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free